CHA Vaccine Research Institute (KOSDAQ:261780)

KOSDAQ:261780 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	112,700	75,894	82,084	151,036	131,749	293,364
Market Cap Growth	53.33%	-7.54%	-45.65%	14.64%	-55.09%	-
Enterprise Value	97,869	55,705	53,558	123,500	97,133	290,192
Last Close Price	4195.00	2825.00	3060.00	5650.00	4985.00	11100.00
PS Ratio	710.52	478.48	221.45	513.51	734.04	586.73
PB Ratio	9.50	6.40	2.96	4.26	3.95	7.41
P/TBV Ratio	9.69	6.53	2.98	4.27	3.95	7.41
EV/Sales Ratio	-	351.19	144.49	419.89	541.18	580.38
Debt / Equity Ratio	0.75	0.75	0.35	0.12	0.71	0.53
Net Debt / Equity Ratio	-1.25	-1.25	-1.10	-0.98	-1.02	-1.03
Net Debt / EBITDA Ratio	1.07	1.07	4.24	5.87	5.64	6.97
Net Debt / FCF Ratio	1.33	1.33	3.69	6.20	6.06	7.51
Asset Turnover	0.00	0.00	0.01	0.01	0.00	0.01
Quick Ratio	1.49	1.49	4.21	48.57	2.18	2.50
Current Ratio	1.66	1.66	4.64	52.44	2.20	2.50
Return on Equity (ROE)	-81.07%	-81.07%	-32.11%	-5.09%	-18.40%	-89.44%
Return on Assets (ROA)	-23.16%	-23.16%	-10.42%	-7.56%	-6.40%	-8.35%
Return on Capital Employed (ROCE)	-105.00%	-105.00%	-20.50%	-14.50%	-18.90%	-15.00%
Earnings Yield	-14.24%	-21.14%	-12.35%	-1.16%	-5.10%	-6.28%
FCF Yield	-9.88%	-14.67%	-10.08%	-3.69%	-4.28%	-1.85%
Buyback Yield / Dilution	-0.20%	-0.20%	-0.76%	-0.69%	-13.39%	-30.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.